Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group.

Senna R MunnikhuysenPrincess A EkpoWei XueZhengya GaoPhilip J LupoRajkumar VenkatramaniChristine M Heske

Published in: Cancer medicine (2023)

While NHB and Hispanic patients enrolled in COG trials presented with higher risk features than NHW patients, there were no outcome differences by racial or ethnic group.

Keyphrases

end stage renal disease
clinical trial
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
type diabetes
skeletal muscle
insulin resistance